Durvalumab in combination with chemotherapy significantly reduced the risk of recurrence, progression or death by 32% compared with neoadjuvant chemotherapy alone.

Those negotiated prices should lower the cost of drugs used by millions of older Americans to help manage diabetes, blood cancers and to prevent heart failure or blood clots.

NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes. The Food and Drug Administration (FDA) has expanded the approval of ...

The new targets support reaching a daily sodium intake of 2750mg per day per person. HealthDay News — The US Food and Drug Administration on Thursday announced Phase 2 of its initial efforts to cut ...

"The potential for further spread within Africa and beyond is very worrying,” said Dr Tedros Adhanom Ghebreyesus in a WHO news release. HealthDay News — The World Health Organization on Wednesday made ...

Kloxxado is intended for immediate administration as emergency therapy in settings where opioids may be present. The shelf-life for Kloxxado ® (naloxone HCl) nasal spray has been extended from 24 ...

The Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for durvalumab ( Imfinzi ®) for the treatment of limited-stage small cell ...

CHIKV VLP is an adjuvanted virus-like particle (VLP)-based vaccine candidate for active immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older.

Axatilimab is a humanized IgG4 monoclonal antibody that targets colony stimulating factor-1 receptors expressed on monocytes and macrophages.

For patients with high MS activity, small increase in relapse risk seen after booster dose, especially for those not treated ...

The Food and Drug Administration (FDA) has granted accelerated approval to Livdelzi ® (seladelpar) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UCDA ...

Pandemic brought loss of immunity to the virus, which has now translated into higher infection rates across the U.S.